# ITERUM THERAPEUTICS PLC SHS NEW (ITRMXXXX)

> Institutional ownership reported to the SEC as of Q4 2025, from Form 13F filings. Source: https://holderbook.com/stocks/ITRMXXXX/

- Reporting holders: 4
- Reported value: $74.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CAPTRUST FINANCIAL ADVISORS](https://holderbook.com/funds/1512024-captrust-financial-advisors/) | $46.4K | 138,600 | 0.0% | 3 |
| [Gen-Wealth Partners Inc](https://holderbook.com/funds/2023375-gen-wealth-partners-inc/) | $28.4K | 84,630 | 0.0% | 2 |
| [BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/1352860-blue-bell-private-wealth-management-llc/) | $22 | 66 | 0.0% | 8 |
| [Cypress Capital Management LLC (WY)](https://holderbook.com/funds/1633896-cypress-capital-management-llc-wy/) | $22 | 66 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2025 | 4 | $74.8K |
| Q3 2025 | 4 | $129.8K |
| Q2 2025 | 3 | $87.2K |
| Q1 2025 | 2 | $86.1K |
| Q4 2024 | 4 | $106.3K |
| Q3 2024 | 3 | $158 |
| Q2 2024 | 1 | $76 |
| Q1 2024 | 2 | $161 |
| Q4 2023 | 2 | $205 |
| Q3 2023 | 2 | $83 |
| Q2 2023 | 2 | $112 |
| Q1 2023 | 2 | $104 |